Get the latest tech news
Kyoto University team develops pain reliever comparable to morphine
Morphine, often administered to cancer patients, has serious adverse effects such as breathing issues and addiction.
According to the team, the newly developed drug, Adriana, is a groundbreaking painkiller, which works on a completely different mechanism to morphine and other existing synthetic opioids. In a clinical trial conducted at the Kyoto University Hospital between January 2023 and December 2024, the team confirmed the new drug's efficiency to a certain extent for patients including 20 who underwent lung cancer surgery. The team plans to conduct a clinical trial in the United States for 400 postsurgery patients in 2026, aiming to put Adriana into practical use in 2028.
Or read this on Hacker News